The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say. The oral drug, dimethylfumarate, or DMF, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback